Sign in
4

Changes in Ownership

Mineralys Therapeutics, Inc. Filed Acc 0001933414-24-000052

Chief Medical Officer sold 25,482 shares at $15.03 ($383,066)

  • Chief Medical Officer acquired 25,482 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Rodman David Malcom Chief Medical Officer 2024-11-06 Option exercise 10b5-1 +25,482 $1.08 $27,521 161,456 D
Rodman David Malcom Chief Medical Officer 2024-11-06 Sale 10b5-1 −25,482 $15.03 $383,066 135,974 D
Derivatives
Rodman David Malcom Chief Medical Officer 2024-11-06 Option exercise · Stock Option 10b5-1 −25,482 139,952 D
Open-market sales · 25,482 sh · avg $15.03 · $383,066
Loading xslF345X05/wk-form4_1731100892.xml…